Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Courtney L Scaife

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
Journal of Medicinal Chemistry|January 13, 2015
Design, synthesis, and biological evaluation of sulfonyl acrylonitriles as novel inhibitors of cancer metastasis and spreadYi Shen, Craig A Zificsak, Jill E Shea, et al.
American Journal of Surgery|December 16, 2003
Is there a role for surgery in patients with "unresectable" cKIT+ gastrointestinal stromal tumors treated with imatinib mesylate?Courtney L Scaife, Kelly K Hunt, Shreyaskumar R Patel, et al.
Surgery|September 2, 2018
Surgical overtreatment of pancreatic intraductal papillary mucinous neoplasms: Do the 2017 International Consensus Guidelines improve clinical decision making?Jeremy M Sharib, Annabelle L Fonseca, Douglas S Swords, et al.
Annals of Surgical Oncology|October 31, 2006
Surgical resection of gastrointestinal stromal tumors after treatment with imatinibRobert H I Andtbacka, Chaan S Ng, Courtney L Scaife, et al.
Annals of Surgical Oncology|May 8, 2003
Feasibility of adjuvant hepatic arterial infusion of chemotherapy after radiofrequency ablation with or without resection in patients with hepatic metastases from colorectal cancerCourtney L Scaife, Steven A Curley, Francesco Izzo, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 20, 2008
Evolution from heterozygous to homozygous KIT mutation in gastrointestinal stromal tumor correlates with the mechanism of mitotic nondisjunction and significant tumor progressionLei L Chen, Joseph A Holden, Haesun Choi, et al.
JCO Clinical Cancer Informatics|March 13, 2023
Multianalyte Serum Biomarker Panel for Early Detection of Pancreatic AdenocarcinomaMatthew A Firpo, Kenneth M Boucher, Josh Bleicher, et al.
Cancer Research Communications|September 18, 2023
Integrated Molecular Characterization of Intraductal Papillary Mucinous Neoplasms: An NCI Cancer Moonshot Precancer Atlas Pilot ProjectAlexander Semaan, Vincent Bernard, Justin Wong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 2, 2022
Diminished Immune Surveillance during Histologic Progression of Intraductal Papillary Mucinous Neoplasms Offers a Therapeutic Opportunity for Cancer InterceptionSharia Hernandez, Edwin Roger Parra, Naohiro Uraoka, et al.
Nature Medicine|March 29, 2019
Publisher Correction: Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancersConan G Kinsey, Soledad A Camolotto, Amelie M Boespflug, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Journal of Medicinal Chemistry|January 13, 2015
Design, synthesis, and biological evaluation of sulfonyl acrylonitriles as novel inhibitors of cancer metastasis and spreadYi Shen, Craig A Zificsak, Jill E Shea, et al.
American Journal of Surgery|December 16, 2003
Is there a role for surgery in patients with "unresectable" cKIT+ gastrointestinal stromal tumors treated with imatinib mesylate?Courtney L Scaife, Kelly K Hunt, Shreyaskumar R Patel, et al.
Surgery|September 2, 2018
Surgical overtreatment of pancreatic intraductal papillary mucinous neoplasms: Do the 2017 International Consensus Guidelines improve clinical decision making?Jeremy M Sharib, Annabelle L Fonseca, Douglas S Swords, et al.
Annals of Surgical Oncology|October 31, 2006
Surgical resection of gastrointestinal stromal tumors after treatment with imatinibRobert H I Andtbacka, Chaan S Ng, Courtney L Scaife, et al.
Annals of Surgical Oncology|May 8, 2003
Feasibility of adjuvant hepatic arterial infusion of chemotherapy after radiofrequency ablation with or without resection in patients with hepatic metastases from colorectal cancerCourtney L Scaife, Steven A Curley, Francesco Izzo, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 20, 2008
Evolution from heterozygous to homozygous KIT mutation in gastrointestinal stromal tumor correlates with the mechanism of mitotic nondisjunction and significant tumor progressionLei L Chen, Joseph A Holden, Haesun Choi, et al.
JCO Clinical Cancer Informatics|March 13, 2023
Multianalyte Serum Biomarker Panel for Early Detection of Pancreatic AdenocarcinomaMatthew A Firpo, Kenneth M Boucher, Josh Bleicher, et al.
Cancer Research Communications|September 18, 2023
Integrated Molecular Characterization of Intraductal Papillary Mucinous Neoplasms: An NCI Cancer Moonshot Precancer Atlas Pilot ProjectAlexander Semaan, Vincent Bernard, Justin Wong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 2, 2022
Diminished Immune Surveillance during Histologic Progression of Intraductal Papillary Mucinous Neoplasms Offers a Therapeutic Opportunity for Cancer InterceptionSharia Hernandez, Edwin Roger Parra, Naohiro Uraoka, et al.
Nature Medicine|March 29, 2019
Publisher Correction: Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancersConan G Kinsey, Soledad A Camolotto, Amelie M Boespflug, et al.
Pageof 8